Cointime

PostEra

company

About

PostEra is a biotech company using its advances in machine learning for medicinal chemistry to get more cures to patients

  • 11 - 50

Highlights

Total Funding Amount
$24.15M
Funding Rounds
3
Investors
2
Investments
1

Details

Last Funding Type
Grant
Industries
Artificial Intelligence,Biotechnology,Machine Learning,Pharmaceutical,Therapeutics
Founded date
Oct 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

PostEra uses machine learning to close the design-make-test loop of medicinal chemistry to advance drug discovery. The company was founded in 2019 and is based in Boston, MA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$24.15M
PostEra has raised a total of $24.15M in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2022 Grant — 1 National Institutes of Health — Detail
Jan 11, 2022 Series A $24M 1 — — Detail
Mar 16, 2020 Seed $150K 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
PostEra has made 1 investments. Their most recent investment was on Mar 5, 2015, when Janaadhar raised ₹540M.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 5, 2015 Janaadhar
Series Unknown ₹540M Construction —

Investors

Number of Lead Investors
Number of Investors
1
2
PostEra is funded by 2 investors. National Institutes of Health and ACE & Company are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
ACE & Company — Series A
Cointime
Chủ Đề
Công Ty